<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article article-type="research-article"><?properties open_access?><!-- Original-type: ra--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id><journal-title>British Journal of Cancer</journal-title><issn pub-type="ppub">0007-0920</issn><issn pub-type="epub">1532-1827</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">11207037</article-id><article-id pub-id-type="pmc">2363765</article-id><article-id pub-id-type="pii">6691643</article-id><article-id pub-id-type="doi">10.1054/bjoc.2000.1643</article-id><article-categories><subj-group subj-group-type="heading"><subject>Regular Article</subject></subj-group></article-categories><title-group><article-title>Estimation of glomerular filtration rate in cancer patients</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Wright</surname><given-names>J G</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Boddy</surname><given-names>A V</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Highley</surname><given-names>M</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fenwick</surname><given-names>J</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>McGill</surname><given-names>A</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Calvert</surname><given-names>A H</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Departments of Oncology</aff><aff id="aff2"><label>2</label>Medical Physics</aff><aff id="aff3"><label>3</label>Clinical Biochemistry, University of Newcastle, NE2 4HH, UK</aff><pub-date pub-type="ppub"><month>02</month><year>2001</year></pub-date><volume>84</volume><issue>4</issue><fpage>452</fpage><lpage>459</lpage><history><date date-type="received"><day>17</day><month>05</month><year>2000</year></date><date date-type="rev-recd"><day>11</day><month>10</month><year>2000</year></date><date date-type="accepted"><day>21</day><month>11</month><year>2000</year></date></history><copyright-statement>Copyright 2001, Cancer Research Campaign</copyright-statement><copyright-year>2001</copyright-year><permissions><copyright-holder>Cancer Research Campaign</copyright-holder></permissions><abstract><p>The frequent need to obtain an estimate of renal function in cancer patients, not least for targeting carboplatin dose, has led to a number of approaches to estimate glomerular filtration rate (GFR). This study aimed to develop a simple and reliable method to estimate GFR using readily-available patient characteristics. Data from 62 patients with estimates of<sup>51</sup>Cr-EDTA clearance were analysed to determine the most appropriate formula relating this method of measuring GFR to patient characteristics. The population pharmacokinetics of<sup>51</sup>Cr-EDTA were analysed using NONMEM to evaluate the influence of each covariate. The formulae derived were then validated using a further 38 patients and compared with those obtained using existing formulae<sup>51</sup>Cr-EDTA clearance (GFR) was positively related to Dubois surface area, negatively related to age, and inversely related to serum creatinine (SCr). Females had lower<sup>51</sup>Cr-EDTA clearance than males. The enzymatic method of SCr assay gave more reliable results than the Jaffe colorimetric method. A measure of creatine kinase significantly improved the estimation of GFR. The new formula produced estimates of GFR which were less biased (Mean Prediction Error = &#x02013;3&#x00025;) and more precise (Mean Absolute Prediction Error = 12&#x00025;) than Cockcroft and Gault (&#x02013;8&#x00025; and 16&#x00025;) or Jelliffe (&#x02013;15&#x00025; and 19&#x00025;) estimates. The formulae developed here can be used to provide reliable estimates of GFR, particularly in regard to targeted dosing of carboplatin. &#x000a9; 2001 Cancer Research Campaign <ext-link ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.bjcancer.com">http://www.bjcancer.com</ext-link></p></abstract><kwd-group><kwd>glomerular filtration</kwd><kwd>renal function</kwd><kwd>EDTA</kwd><kwd>population pharmacokinetics</kwd></kwd-group></article-meta></front></article>


